名稱 | BCR-ABL1 P223S/BaF3 |
型號(hào) | CBP73310 |
報(bào)價(jià) | ![]() |
特點(diǎn) | BCR-ABL1 [P223S]/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO; |
產(chǎn)品搜索
相關(guān)文章
- JCI:華人科學(xué)家發(fā)現(xiàn)促進(jìn)乳腺癌進(jìn)展轉(zhuǎn)移的表觀修飾閱讀者
- 百時(shí)美免疫組合治療非小細(xì)胞肺癌展現(xiàn)驚人療效
- 長(zhǎng)期研究使用的腦癌細(xì)胞系或面臨“身份危機(jī)”
- GLP1R藥靶篩選模型應(yīng)用展示
- IL2細(xì)胞篩選模型
- 選擇進(jìn)口的細(xì)胞株這幾點(diǎn)千萬不能忘!
- 科學(xué)家如何深度破解癌癥基因組的奧秘?
- 腫瘤細(xì)胞能無限分裂的原因有哪些?
- PDGFRA靶點(diǎn)藥物細(xì)胞篩選模型
- 肺癌靶向治療:腫瘤不進(jìn)展時(shí)間超2年
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73310BCR-ABL1 P223S/BaF3

- 詳細(xì)內(nèi)容
CBP73310 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [P223S]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1.WB of BCR-ABL1 [P223S]/BaF3 | |
2.Sanger of BCR-ABL1 [P223S]/BaF3 Figure 2. BCR-ABL1 [P223S]/BaF3 P223S Figure 3. BCR-ABL1 [P223S]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 P223S Cells (C14). | |